Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Clinical Research and Equipment Industry Analysis

UpdatedJul 30, 2026
DataAggregated Company Financials
Companies9
  • 7D0.4%
  • 3M8.6%
  • 1Y-17.5%
  • YTDn/a

In the last week, the Clinical Research and Equipment industry is up 1.5%, with AddLife up 3.3%. In the same time, MedCap was down 6.9%. However, the industry is down 16% over the past year. Looking forward, earnings are forecast to grow by 17% annually.

Industry Valuation and Performance

Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 30 Jul 2026SEK 30.3bSEK 14.8b-SEK 829,177,579.0033.3x-36.6x2x
Sat, 27 Jun 2026SEK 31.2bSEK 14.6b-SEK 871,304,353.0036.5x-35.8x2.1x
Mon, 25 May 2026SEK 30.0bSEK 14.6b-SEK 849,175,077.0037.7x-35.4x2.1x
Wed, 22 Apr 2026SEK 31.3bSEK 14.6b-SEK 971,664,077.0036.6x-32.3x2.1x
Fri, 20 Mar 2026SEK 26.5bSEK 14.6b-SEK 838,374,077.0031.7x-31.6x1.8x
Sun, 15 Feb 2026SEK 27.0bSEK 14.9b-SEK 553,301,427.0032.8x-48.8x1.8x
Tue, 13 Jan 2026SEK 30.7bSEK 14.9b-SEK 744,515,427.0048.1x-41.2x2.1x
Thu, 11 Dec 2025SEK 33.0bSEK 14.9b-SEK 744,515,427.0054.9x-44.3x2.2x
Sat, 08 Nov 2025SEK 34.5bSEK 14.7b-SEK 742,825,012.0051.6x-46.4x2.3x
Mon, 06 Oct 2025SEK 34.5bSEK 14.7bSEK 61.3m58.7x562.8x2.4x
Wed, 03 Sep 2025SEK 34.5bSEK 14.7bSEK 60.9m55.4x566.4x2.4x
Fri, 01 Aug 2025SEK 36.2bSEK 14.8bSEK 186.0m59.2x194.9x2.5x
Sun, 29 Jun 2025SEK 46.7bSEK 16.6bSEK 405.8m68.5x115.1x2.8x
Tue, 27 May 2025SEK 45.9bSEK 16.6bSEK 401.3m69.5x114.4x2.8x
Thu, 24 Apr 2025SEK 41.8bSEK 16.6bSEK 580.4m45.7x72x2.5x
Sat, 22 Mar 2025SEK 37.2bSEK 16.6bSEK 614.3m38x60.5x2.2x
Mon, 17 Feb 2025SEK 43.7bSEK 17.0b-SEK 1,033,505,426.0042.5x-42.3x2.6x
Wed, 15 Jan 2025SEK 40.7bSEK 16.7b-SEK 1,152,911,426.0041.9x-35.3x2.4x
Fri, 13 Dec 2024SEK 44.2bSEK 16.7b-SEK 1,152,911,426.0050.8x-38.3x2.6x
Sun, 10 Nov 2024SEK 44.3bSEK 16.8b-SEK 948,072,426.0050.7x-46.8x2.6x
Tue, 08 Oct 2024SEK 46.8bSEK 16.7b-SEK 988,175,491.0057.9x-47.3x2.8x
Thu, 05 Sep 2024SEK 48.0bSEK 16.7b-SEK 987,374,492.0060.7x-48.6x2.9x
Sat, 03 Aug 2024SEK 47.4bSEK 16.7b-SEK 1,128,120,510.0059.9x-42x2.8x
Mon, 01 Jul 2024SEK 42.0bSEK 16.3b-SEK 1,188,686,510.0055.3x-35.3x2.6x
Wed, 29 May 2024SEK 42.2bSEK 16.3b-SEK 1,188,686,510.0060.3x-35.5x2.6x
Fri, 26 Apr 2024SEK 37.0bSEK 16.3b-SEK 1,244,732,213.0035.5x-29.7x2.3x
Sun, 24 Mar 2024SEK 38.8bSEK 16.0b-SEK 1,122,792,210.0036x-34.6x2.4x
Tue, 20 Feb 2024SEK 40.8bSEK 16.1b-SEK 1,406,407,350.0047.3x-29x2.5x
Thu, 18 Jan 2024SEK 36.4bSEK 15.5b-SEK 1,393,723,683.0044x-26.1x2.4x
Sat, 16 Dec 2023SEK 38.2bSEK 15.5b-SEK 1,393,723,683.0047.6x-27.4x2.5x
Mon, 13 Nov 2023SEK 31.2bSEK 15.4b-SEK 1,256,647,710.0034x-24.8x2x
Wed, 11 Oct 2023SEK 26.5bSEK 15.1b-SEK 1,134,516,711.0035.7x-23.4x1.8x
Fri, 08 Sep 2023SEK 29.2bSEK 15.1b-SEK 1,133,713,072.0038.1x-25.8x1.9x
Sun, 06 Aug 2023SEK 32.1bSEK 15.1b-SEK 213,871,038.0046.7x-150.2x2.1x
Price to Earnings Ratio

-150.2x


Total Market Cap: SEK 32.1bTotal Earnings: -SEK 213,871,038.00Total Revenue: SEK 15.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Clinical Research and Equipment Industry Price to Earnings3Y Average 26.1x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 2.4x is higher than the industry's current PS ratio of 2.1x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Swedish Clinical Research and Equipment compare with similar industries?

SE Market1.31%
Healthcare1.71%
Life Sciences0.42%
Clinical Research and Equipment0.42%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ALIF B AddLifeSEK 162.504.4%
+SEK 828.7m		-6.0%PE33.1x
BICO BICO GroupSEK 14.327.7%
+SEK 72.0m		-60.8%PS0.7x
GENO Genovis AB (publ.)SEK 19.723.7%
+SEK 47.2m		-27.0%PE64.9x
MCAP MedCapSEK 551.500.5%
+SEK 37.4m		-15.5%PE34.3x
ATANA AttanaSEK 0.00350.0%
+SEK 2.6m		-88.5%PS2.7x

Latest News

PEXA B
SEK 0.23
PExA
7D
-1.7%
1Y
-40.4%
BICO
SEK 14.32
BICO Group
7D
7.7%
1Y
-60.8%
Narrative Update • Jul 29

BICO: Incentive Programme And Margin Focus Will Support Future Upside

Analysts have adjusted their view on BICO Group, with the fair value estimate moving from SEK 40 to SEK 31. This change reflects updated assumptions on the discount rate, revenue growth, profit margin, and future P/E multiples.
GENO
SEK 19.72
Genovis AB (publ.)
7D
3.7%
1Y
-27.0%
Analysis Article • Jul 27

Earnings Miss: Genovis AB (publ.) Missed EPS By 78% And Analysts Are Revising Their Forecasts

Genovis AB (publ.) ( STO:GENO ) missed earnings with its latest quarterly results, disappointing overly-optimistic...
MCAP
SEK 551.50
MedCap
7D
0.5%
1Y
-15.5%
Analysis Article • Jul 24

MedCap AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

MedCap AB (publ) ( STO:MCAP ) just released its latest second-quarter results and things are looking bullish. It was...
ALIF B
SEK 162.50
AddLife
7D
4.4%
1Y
-6.0%
Analysis Article • Jul 20

Analyst Estimates: Here's What Brokers Think Of AddLife AB (publ) (STO:ALIF B) After Its Second-Quarter Report

AddLife AB (publ) ( STO:ALIF B ) last week reported its latest quarterly results, which makes it a good time for...
MAGLE
SEK 0.51
Magle Chemoswed Holding
7D
-50.5%
1Y
-97.6%
IDLDX
SEK 0.41
IDL Diagnostics
7D
1.0%
1Y
-29.5%
ATANA
SEK 0.003
Attana
7D
50.0%
1Y
-88.5%
PRO
SEK 10.10
Promimic
7D
1.0%
1Y
-47.1%
LEVBIO
SEK 0.25
Level Bio
7D
-13.2%
1Y
-13.8%